These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 31127887

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
    Sarkar FH, Valdivieso M, Borders J, Yao KL, Raval MM, Madan SK, Sreepathi P, Shimoyama R, Steiger Z, Visscher DW.
    Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Relationship of epidermal growth factor receptor gene mutations, clinicopathologic features and prognosis in patients with non-small cell lung cancer].
    Fan MJ, Li HG, Lü ZQ, Zhang HZ, Shen XM.
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):679-82. PubMed ID: 22321547
    [Abstract] [Full Text] [Related]

  • 5. [Relationship between EGFR and KRAS mutations and prognosis in Chinese patients with non-small cell lung cancer: a mutation analysis with real-time polymerase chain reaction using scorpion amplification refractory mutation system].
    Gao J, Chen JQ, Zhang L, Liang ZY.
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):652-6. PubMed ID: 23302304
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Frequency of EGFR mutations in non-small cell lung cancer patients: screening data from West Siberia.
    Gervas P, Ivanova A, Vasiliev N, Ananina O, Zharkova O, Rogovieva O, Verzhbitskaya N, Didichuk I, Cheremisina O, Popova N, Goldberg V, Cherdyntsev E, Choynzonov E, Cherdyntseva N.
    Asian Pac J Cancer Prev; 2015 Oct; 16(2):689-92. PubMed ID: 25684509
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relationship between epidermal growth factor receptor gene mutations and clinicopathological features in patients with non-small cell lung cancer in western Turkey.
    Unal OU, Oztop I, Calibasi G, Baskin Y, Koca D, Demir N, Akman T, Ellidokuz H, Yilmaz AU.
    Asian Pac J Cancer Prev; 2013 Oct; 14(6):3705-9. PubMed ID: 23886169
    [Abstract] [Full Text] [Related]

  • 10. EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment.
    Marchetti A, Martella C, Felicioni L, Barassi F, Salvatore S, Chella A, Camplese PP, Iarussi T, Mucilli F, Mezzetti A, Cuccurullo F, Sacco R, Buttitta F.
    J Clin Oncol; 2005 Feb 01; 23(4):857-65. PubMed ID: 15681531
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increase EGFR Mutations Detection Rate in Lung Adenocarcinoma by Real-Time PCR Screening Followed by Direct Sequencing.
    Er TK, Lin CW, Liu TC, Chen CC, Wang LH, Hsieh LL, Tsai WC.
    Appl Immunohistochem Mol Morphol; 2015 Feb 01; 23(5):343-8. PubMed ID: 25961746
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Relationship between mutations of epidermal growth factor receptor gene and clinicopathologic features of non-small cell lung cancers].
    Wang F, Fu S, Tang T, Deng L, Zhang X, Li YZ, Shao JY.
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct 01; 40(10):664-6. PubMed ID: 22321543
    [Abstract] [Full Text] [Related]

  • 16. [Detection of epidermal growth factor receptor mutations in non-small-cell lung carcinoma by direct sequencing and correlations with clinicopathological characteristics and sample types].
    Sun MH, Yang F, Shen L, Zhang L, Chen Y, Cai X, Zhu XL, Zhou XY.
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct 01; 40(10):655-9. PubMed ID: 22321541
    [Abstract] [Full Text] [Related]

  • 17. MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.
    Beau-Faller M, Ruppert AM, Voegeli AC, Neuville A, Meyer N, Guerin E, Legrain M, Mennecier B, Wihlm JM, Massard G, Quoix E, Oudet P, Gaub MP.
    J Thorac Oncol; 2008 Apr 01; 3(4):331-9. PubMed ID: 18379349
    [Abstract] [Full Text] [Related]

  • 18. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer.
    Ludovini V, Bianconi F, Pistola L, Chiari R, Minotti V, Colella R, Giuffrida D, Tofanetti FR, Siggillino A, Flacco A, Baldelli E, Iacono D, Mameli MG, Cavaliere A, Crinò L.
    J Thorac Oncol; 2011 Apr 01; 6(4):707-15. PubMed ID: 21258250
    [Abstract] [Full Text] [Related]

  • 19. Comparison of epidermal growth factor receptor mutation detection turnaround times and concordance among real-time polymerase chain reaction, high-throughput next-generation sequencing and the Biocartis Idylla™ platforms in non-small cell lung carcinomas.
    Sharma S, Satapathy A, Aggarwal A, Dewan A, Jain E, Katara R, Kumar V, Pal R, Pandey S, Naidu MM, Kini L, Pradhan D, Mohanty SK.
    Pathol Res Pract; 2021 Apr 01; 220():153394. PubMed ID: 33706124
    [Abstract] [Full Text] [Related]

  • 20. Detection of DNA mutations in acid formalin-fixed paraffin-embedded archival tumor specimens by polymerase chain reaction-single strand conformation polymorphism analysis.
    Marchetti A, Merlo G, Buttitta F, Pellegrini S, Callahan R, Bistocchi M, Squartini F.
    Cancer Detect Prev; 1995 Apr 01; 19(3):278-81. PubMed ID: 7750117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.